Adapting a home telemonitoring intervention for underserved Hispanic/Latino patients with type 2 diabetes: an acceptability and feasibility study.
Culturally Competent Care
/ methods
Diabetes Mellitus, Type 2
/ therapy
Feasibility Studies
Focus Groups
Health Promotion
/ methods
Healthcare Disparities
Hispanic or Latino
/ psychology
Humans
Interviews as Topic
Monitoring, Ambulatory
/ methods
Patient Acceptance of Health Care
Pilot Projects
Qualitative Research
Telemedicine
/ methods
Vulnerable Populations
ADAPT-ITT
Feasibility
Hispanic/Latino population
Home telemedicine
Type 2 diabetes
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
07 12 2020
07 12 2020
Historique:
received:
09
06
2020
accepted:
22
11
2020
entrez:
8
12
2020
pubmed:
9
12
2020
medline:
12
1
2021
Statut:
epublish
Résumé
Home telemonitoring is a promising approach to optimizing outcomes for patients with Type 2 Diabetes; however, this care strategy has not been adapted for use with understudied and underserved Hispanic/Latinos (H/L) patients with Type 2 Diabetes. A formative, Community-Based Participatory Research approach was used to adapt a home telemonitoring intervention to facilitate acceptability and feasibility for vulnerable H/L patients. Utilizing the ADAPT-ITT framework, key stakeholders were engaged over an 8-month iterative process using a combination of strategies, including focus groups and structured interviews. Nine Community Advisory Board, Patient Advisory, and Provider Panel Committee focus group discussions were conducted, in English and Spanish, to garner stakeholder input before intervention implementation. Focus groups and structured interviews were also conducted with 12 patients enrolled in a 1-month pilot study, to obtain feedback from patients in the home to further adapt the intervention. Focus groups and structured interviews were approximately 2 hours and 30 min, respectively. All focus groups and structured interviews were audio-recorded and professionally transcribed. Structural coding was used to mark responses to topical questions in the moderator and interview guides. Two major themes emerged from qualitative analyses of Community Advisory Board/subcommittee focus group data. The first major theme involved intervention components to maximize acceptance/usability. Subthemes included tablet screens (e.g., privacy/identity concerns; enlarging font sizes; lighter tablet to facilitate portability); cultural incongruence (e.g., language translation/literacy, foods, actors "who look like me"); nursing staff (e.g., ensuring accessibility; appointment flexibility); and, educational videos (e.g., the importance of information repetition). A second major theme involved suggested changes to the randomized control trial study structure to maximize participation, including a major restructuring of the consenting process and changes designed to optimize recruitment strategies. Themes from pilot participant focus group/structured interviews were similar to those of the Community Advisory Board such as the need to address and simplify a burdensome consenting process, the importance of assuring privacy, and an accessible, culturally congruent nurse. These findings identify important adaptation recommendations from the stakeholder and potential user perspective that should be considered when implementing home telemonitoring for underserved patients with Type 2 Diabetes. NCT03960424; ClinicalTrials.gov (US National Institutes of Health). Registered 23 May 2019. Registered prior to data collection. https://www.clinicaltrials.gov/ct2/show/NCT03960424?term=NCT03960424&draw=2&rank=1.
Sections du résumé
BACKGROUND
Home telemonitoring is a promising approach to optimizing outcomes for patients with Type 2 Diabetes; however, this care strategy has not been adapted for use with understudied and underserved Hispanic/Latinos (H/L) patients with Type 2 Diabetes.
METHODS
A formative, Community-Based Participatory Research approach was used to adapt a home telemonitoring intervention to facilitate acceptability and feasibility for vulnerable H/L patients. Utilizing the ADAPT-ITT framework, key stakeholders were engaged over an 8-month iterative process using a combination of strategies, including focus groups and structured interviews. Nine Community Advisory Board, Patient Advisory, and Provider Panel Committee focus group discussions were conducted, in English and Spanish, to garner stakeholder input before intervention implementation. Focus groups and structured interviews were also conducted with 12 patients enrolled in a 1-month pilot study, to obtain feedback from patients in the home to further adapt the intervention. Focus groups and structured interviews were approximately 2 hours and 30 min, respectively. All focus groups and structured interviews were audio-recorded and professionally transcribed. Structural coding was used to mark responses to topical questions in the moderator and interview guides.
RESULTS
Two major themes emerged from qualitative analyses of Community Advisory Board/subcommittee focus group data. The first major theme involved intervention components to maximize acceptance/usability. Subthemes included tablet screens (e.g., privacy/identity concerns; enlarging font sizes; lighter tablet to facilitate portability); cultural incongruence (e.g., language translation/literacy, foods, actors "who look like me"); nursing staff (e.g., ensuring accessibility; appointment flexibility); and, educational videos (e.g., the importance of information repetition). A second major theme involved suggested changes to the randomized control trial study structure to maximize participation, including a major restructuring of the consenting process and changes designed to optimize recruitment strategies. Themes from pilot participant focus group/structured interviews were similar to those of the Community Advisory Board such as the need to address and simplify a burdensome consenting process, the importance of assuring privacy, and an accessible, culturally congruent nurse.
CONCLUSIONS
These findings identify important adaptation recommendations from the stakeholder and potential user perspective that should be considered when implementing home telemonitoring for underserved patients with Type 2 Diabetes.
TRIAL REGISTRATION
NCT03960424; ClinicalTrials.gov (US National Institutes of Health). Registered 23 May 2019. Registered prior to data collection. https://www.clinicaltrials.gov/ct2/show/NCT03960424?term=NCT03960424&draw=2&rank=1.
Identifiants
pubmed: 33287815
doi: 10.1186/s12911-020-01346-0
pii: 10.1186/s12911-020-01346-0
pmc: PMC7720574
doi:
Banques de données
ClinicalTrials.gov
['NCT03960424']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
324Subventions
Organisme : Patient-Centered Outcomes Research Institute (US)
ID : AD-2017C3-9185
Pays : International
Références
Heart Lung. 2001 May-Jun;30(3):191-9
pubmed: 11343005
Womens Health Issues. 2007 May-Jun;17(3):150-61
pubmed: 17475506
Diabetes Care. 2010 Aug;33(8):1712-7
pubmed: 20484125
Educ Health (Abingdon). 2001;14(2):182-97
pubmed: 14742017
Stat Med. 1990 Jun;9(6):645-56
pubmed: 2218168
Sci Rep. 2017 Oct 4;7(1):12680
pubmed: 28978949
Fam Syst Health. 2014 Mar;32(1):78-88
pubmed: 24079815
Diabetes Care. 2009 Jun;32(6):1115-8
pubmed: 19460917
CMAJ. 2017 Mar 6;189(9):E341-E364
pubmed: 27799615
Ann Intern Med. 1996 Aug 1;125(3):221-32
pubmed: 8686981
Diabetes Care. 1998 Aug;21(8):1230-5
pubmed: 9702425
Diabetologia. 2012 Jun;55(6):1577-96
pubmed: 22526604
Ethn Dis. 2013 Autumn;23(4):401-8
pubmed: 24392600
PLoS One. 2017 Mar 1;12(3):e0173160
pubmed: 28249025
JAMA. 2002 May 15;287(19):2519-27
pubmed: 12020332
Diabetes Educ. 2017 Feb;43(1):54-77
pubmed: 28118127
Health Promot Pract. 2006 Jul;7(3):312-23
pubmed: 16760238
Diabetes Care. 2018 Jan;41(Suppl 1):S7-S12
pubmed: 29222372
Ethn Health. 2013;18(1):83-96
pubmed: 22762449
Diabetes Obes Metab. 2009 Oct;11(10):913-30
pubmed: 19531058
J Natl Med Assoc. 2002 Aug;94(8):666-8
pubmed: 12152921
Diabetes Res Clin Pract. 2016 Jun;116:136-48
pubmed: 27321329
Lancet Diabetes Endocrinol. 2014 Nov;2(11):867-74
pubmed: 25128274
Arch Intern Med. 2007 Sep 24;167(17):1853-60
pubmed: 17893306
Diabetes Care. 2003 Feb;26(2):495-501
pubmed: 12547888
J Med Internet Res. 2016 Sep 26;18(9):e256
pubmed: 27670360
N Engl J Med. 1989 Oct 19;321(16):1074-9
pubmed: 2797067
Health Soc Care Community. 2012 Jan;20(1):1-19
pubmed: 21749529
Prog Community Health Partnersh. 2010 Summer;4(2):131-40
pubmed: 20543488
JMIR Form Res. 2020 Jan 31;4(1):e13197
pubmed: 32012039
Health Promot Pract. 2005 Jul;6(3):286-98
pubmed: 16020623
Contemp Clin Trials. 2009 Jan;30(1):47-54
pubmed: 18775798
Int J Telemed Appl. 2012;2012:715194
pubmed: 22997511
ANS Adv Nurs Sci. 2004 Jul-Sep;27(3):162-75
pubmed: 15455579
Medicine (Baltimore). 2018 Oct;97(43):e12962
pubmed: 30412116
AIDS Educ Prev. 2014 Oct;26(5):383-97
pubmed: 25299804
J Am Med Inform Assoc. 2009 Jul-Aug;16(4):446-56
pubmed: 19390093
PLoS One. 2013 Nov 08;8(11):e79246
pubmed: 24250826
J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S40-6
pubmed: 18301133